China 923036-30-0 Factory

With this motto in mind, we've turn into one of quite possibly the most technologically innovative, cost-efficient, and price-competitive manufacturers for 923036-30-0,CAS NO 923036-30-0,Tofacitinib intermediate,Tofacitinib advance intermediate,N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl), We have been sincerely wanting forward to cooperate with consumers all over the earth. We feel we can easily satisfy with you. We also warmly welcome buyers to visit our manufacturing unit and purchase our products and solutions.
923036-30-0, By continuous innovation, we will supply you with more valuable merchandise and services, and also make a contribution for the development of the automobile industry at home and abroad. Both domestic and foreign merchants are strongly welcomed to join us to grow together.

Hot Products

  • 2,2'-Dithiosalicylic acid

    2,2'-Dithiosalicylic acid

    Product Name:2,2'-Dithiosalicylic acid
    Molecular Formula:C14H10O4S2
    Molecular Weight:306.36
    CAS Registry Number:119-80-2
  • 1-Hexadecanol

    1-Hexadecanol

    Product Name:1-Hexadecanol
    Molecular Formula:C16H34O
    Molecular Weight:242.44
    CAS Registry Number:36653-82-4
  • Tubulysin A

    Tubulysin A

    Product Name:Tubulysin A
    Molecular Formula:C43H65N5O10S
    Molecular Weight;844.07
    CAS Registry Number;205304-86-5
  • ABT-494 intermediate

    ABT-494 intermediate

    Product Name:ABT-494 intermediate
    Molecular Formula:C15H19NO4
    Molecular Weight:277.32
    CAS Registry Number:1428243-24-6
  • (R)-(+)-1-(1-Naphthyl)ethylamine

    (R)-(+)-1-(1-Naphthyl)ethylamine

    Product Name:(R)-(+)-1-(1-Naphthyl)ethylamine
    Molecular Formula:C12H13N
    Molecular Weight:171.24
    CAS Registry Number:3886-70-2
  • Lanthanum oxide

    Lanthanum oxide

    Product Name:Lanthanum oxide
    Molecular Formula:La2O3
    Molecular Weight:325.81
    CAS Registry Number:1312-81-8

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept